Virus Trial: Anti

Before any human received AVI-7, Elena’s team tested it on human lung cell cultures infected with Phoenix. The drug reduced viral load by 99.9 percent within 48 hours without harming the cells. Next, they used ferrets—the gold standard for flu research—because ferrets cough, sneeze, and develop fever similarly to humans. Treated ferrets recovered fully; untreated ones died or suffered severe pneumonia.

The results, when unblinded, stunned the medical community. Among high-risk patients (elderly, asthmatics, pregnant women), AVI-7 reduced hospitalization rates by 76 percent compared to placebo. Even more remarkable, viral sequencing showed zero resistance mutations after 60 days of treatment—something never seen with oseltamivir (Tamiflu). anti virus trial

Dr. Márquez often told her students: “A trial isn’t a success because the drug works. It’s a success because we honestly learn what it can and cannot do—and we tell the truth about both.” Before any human received AVI-7, Elena’s team tested